BIOCON
Biocon Limited
Pharmaceuticals
Share price
₹416
Market cap
₹67,477 Cr
1Y return
▲ 16%
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
Investors holding Biocon Limited
3.73%
1.24%
1.01%
Latest move
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held a 2.4 percent stake in Biocon Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in its holding to below the 1 percent reporting threshold.
Sign in to read more
Whales made 38 more moves in Biocon Limited
Sign in to see who is buying and selling.
Sign in to find out